|
|
|||||||||||
EDITORIALS |
Mental Health Group, University of Southampton, Southampton
Kent Institute of Medicine and Health Sciences, University of Kent, Canterbury
Department of Psychological Medicine, Kings College Hospital, London
Department of Primary Medical Care, University of Liverpool, Liverpool, UK
Correspondence: Professor Robert Peveler, Mental Health Group, University of Southampton, Royal South Hants Hospital, Southampton SO14 0YG, UK. Tel: +44 (0) 2380 825533; fax: +44 (0) 2380 234243; e-mail: R.C.Peveler{at}soton.ac.uk
Declaration of interest All of the authors were involved in the development of a review on depression and pain which was funded by Eli Lilly and Boehringer Ingelheim. However, the supporting companies were not represented at meetings and played no part in selecting the participants or preparing the report or this editorial. R.P. and C.K. have received speaker fees, hospitality or consultancy fees from Eli Lilly, Wyeth, Lundbeck, Novo Nordisk and Bristol Myers Squibb. S.W. has received support for conference attendance from Eli Lilly.
Current diagnostic systems maintain an artificial division between physicaland psychologicaldisorders. This is exemplified by the way in which pain symptoms are dealt with in the context of depressive illness. The consequences of this are discussed, and ways to enhance the clinical care of patients with depression and pain are suggested.
Related articles in BJP:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |